Synergistic Antiviral Activity of Pamapimod and Pioglitazone against SARS-CoV-2 and Its Variants of Concern

MLA

Christian Setz, et al. “Synergistic Antiviral Activity of Pamapimod and Pioglitazone against SARS-CoV-2 and Its Variants of Concern.” International Journal of Molecular Sciences, vol. 23, no. 12, June 2022, p. 6830. EBSCOhost, https://doi.org/10.3390/ijms23126830.

APA

Christian Setz, Maximilian Große, Janina Auth, Maria Fröba, Pia Rauch, Alexander Bausch, Matthew Wright, & Ulrich Schubert. (2022). Synergistic Antiviral Activity of Pamapimod and Pioglitazone against SARS-CoV-2 and Its Variants of Concern. International Journal of Molecular Sciences, 23(12), 6830. https://doi.org/10.3390/ijms23126830

Chicago

Christian Setz, Maximilian Große, Janina Auth, Maria Fröba, Pia Rauch, Alexander Bausch, Matthew Wright, and Ulrich Schubert. 2022. “Synergistic Antiviral Activity of Pamapimod and Pioglitazone against SARS-CoV-2 and Its Variants of Concern.” International Journal of Molecular Sciences 23 (12): 6830. doi:10.3390/ijms23126830.